Literature DB >> 2876964

Change in degree of type 1 piliation of Escherichia coli during experimental peritonitis in the mouse.

M L Alkan, L Wong, F J Silverblatt.   

Abstract

To determine whether expression of type 1 pili varies during the course of Escherichia coli infection in vivo, mice were injected intraperitoneally with 5 X 10(7) CFU of piliated or nonpiliated phase variants per ml, and the degree of piliation was measured in peritoneal exudate by an enzyme-linked immunosorbent assay inhibition method. In the animals challenged with the piliated bacteria, the numbers of organisms increased a log over 9 h and the amount of pilus antigen decreased from 3 to 0.075 micrograms/10 bacteria. After a 4-h delay, nonpiliated bacteria also increased by one log over 9 h; however, the amount of piliation remained virtually undetectable. Piliated E. coli were more virulent than nonpiliated variants in this model (50% lethal dose of 7.5 X 10(6) versus 3 X 10(7), respectively). The difference was significantly reduced by prior passive immunization with rabbit serum containing high titers of antipili antibody. Piliated bacteria adhered in significantly greater numbers to isolated mouse peritoneal membranes than did nonpiliated variants (15,400 +/- 2,700 versus 1,300 +/- 700 bacteria/mm2, respectively; P = 0.05). Adherence was inhibited by the presence of 0.1 M alpha methyl mannose (1,500 +/- 1,800 bacteria/mm2, P = 0.01). These results confirm the results of previous qualitative studies showing that phase variation of type 1 pili occurs in vivo and suggest that these pili may confer an initial advantage for growth of E. coli in the peritoneal cavity, presumably by fostering colonization of the peritoneal serosal surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876964      PMCID: PMC260196          DOI: 10.1128/iai.54.2.549-554.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Cyclic AMP-dependent synthesis of fimbriae in Salmonella typhimurium: effects of cya and pts mutations.

Authors:  M H Saier; M R Schmidt; M Leibowitz
Journal:  J Bacteriol       Date:  1978-04       Impact factor: 3.490

2.  Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control.

Authors:  B I Eisenstein
Journal:  Science       Date:  1981-10-16       Impact factor: 47.728

3.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

4.  Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice.

Authors:  M C Maayan; I Ofek; O Medalia; M Aronson
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  Dissociation and reassembly of Escherichia coli type 1 pili.

Authors:  Y Eshdat; F J Silverblatt; N Sharon
Journal:  J Bacteriol       Date:  1981-10       Impact factor: 3.490

6.  Effect of pili on susceptibility of Escherichia coli to phagocytosis.

Authors:  F J Silverblatt; J S Dreyer; S Schauer
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Contribution of adhesion to bacterial persistence in the mouse urinary tract.

Authors:  L Hagberg; R Hull; S Hull; S Falkow; R Freter; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

8.  The role of pili and capsule in the pathogenesis of neonatal infection with Escherichia coli K1.

Authors:  N G Guerina; T W Kessler; V J Guerina; M R Neutra; H W Clegg; S Langermann; F A Scannapieco; D A Goldmann
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

9.  Selective outgrowth of fimbriate bacteria in static liquid medium.

Authors:  D C Old; J P Duguid
Journal:  J Bacteriol       Date:  1970-08       Impact factor: 3.490

10.  Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals.

Authors:  A B Onderdonk; W M Weinstein; N M Sullivan; J G Bartlett; S L Gorbach
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  11 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Effect of type 1 piliation on in vitro killing of Escherichia coli by mouse peritoneal macrophages.

Authors:  B R Keith; S L Harris; P W Russell; P E Orndorff
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

Review 3.  Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria.

Authors:  I Ofek; N Sharon
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

4.  In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections.

Authors:  P V Kisielius; W R Schwan; S K Amundsen; J L Duncan; A J Schaeffer
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

5.  Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli.

Authors:  M Arthur; C E Johnson; R H Rubin; R D Arbeit; C Campanelli; C Kim; S Steinbach; M Agarwal; R Wilkinson; R Goldstein
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

6.  Enhanced virulence of Escherichia coli bearing a site-targeted mutation in the major structural subunit of type 1 fimbriae.

Authors:  A K May; C A Bloch; R G Sawyer; M D Spengler; T L Pruett
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Shigella flexneri transformants expressing type 1 (mannose-specific) fimbriae bind to, activate, and are killed by phagocytic cells.

Authors:  A Gbarah; D Mirelman; P J Sansonetti; R Verdon; W Bernhard; N Sharon
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 8.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

9.  Virulence of non-type 1-fimbriated and nonfimbriated nonflagellated Salmonella typhimurium mutants in murine typhoid fever.

Authors:  H A Lockman; R Curtiss
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  Increased type 1 fimbrial expression among commensal Escherichia coli isolates in the murine cecum following catabolic stress.

Authors:  B A Hendrickson; J Guo; R Laughlin; Y Chen; J C Alverdy
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.